Matches in SemOpenAlex for { <https://semopenalex.org/work/W4311108142> ?p ?o ?g. }
- W4311108142 endingPage "7168" @default.
- W4311108142 startingPage "7168" @default.
- W4311108142 abstract "Background: Galectin-3 (Gal-3) is considered a potential cardiovascular inflammatory marker that may provide additional risk stratification for patients with acute heart failure. It is unknown whether mild therapeutic hypothermia (MTH) impacts Gal-3 levels. Therefore, this biomarker study aimed to investigate the effect of MTH on Gal-3. Methods: In the randomized SHOCK-COOL trial, 40 patients with cardiogenic shock (CS) complicating acute myocardial infraction (AMI) were randomly assigned to the MTH (33 °C) or control group in a 1:1 ratio. Blood samples were collected on the day of admission/day 1, day 2, and day 3. Gal-3 level kinetics throughout these time points were compared between the MTH and control groups. Additionally, potential correlations between Gal-3 and clinical patient characteristics were assessed. Multiple imputations were performed to account for missing data. Results: In the control group, Gal-3 levels were significantly lower on day 3 than on day 1 (day 1 vs. day 3: 3.84 [IQR 2.04–13.3] vs. 1.79 [IQR 1.23–3.50] ng/mL; p = 0.049). Gal-3 levels were not significantly different on any day between the MTH and control groups (p for interaction = 0.242). Spearman’s rank correlation test showed no significant correlation between Gal-3 levels and sex, age, smoking, body mass index (BMI), and levels of creatine kinase-MB, creatine kinase, C-reactive protein, creatinine, and white blood cell counts (all p > 0.05). Patients with lower Gal-3 levels on the first day after admission demonstrated a higher risk of all-cause mortality at 30 days (hazard ratio, 2.67; 95% CI, 1.11–6.42; p = 0.029). In addition, Gal-3 levels on day 1 had a good predictive value for 30-day all-cause mortality with an area under the receiver operating characteristic curve of 0.696 (95% CI: 0.513–0.879), with an optimal cut-off point of less than 3651 pg/mL. Conclusions: MTH has no effect on Gal-3 levels in patients with CS complicating AMI compared to the control group. In addition, Gal-3 is a relatively stable biomarker, independent of age, sex, and BMI, and Gal-3 levels at admission might predict the risk of 30-day all-cause mortality." @default.
- W4311108142 created "2022-12-23" @default.
- W4311108142 creator A5021761323 @default.
- W4311108142 creator A5025672693 @default.
- W4311108142 creator A5042017136 @default.
- W4311108142 creator A5042630628 @default.
- W4311108142 creator A5049481596 @default.
- W4311108142 creator A5063880800 @default.
- W4311108142 creator A5065735468 @default.
- W4311108142 creator A5067592420 @default.
- W4311108142 creator A5068678356 @default.
- W4311108142 creator A5087395048 @default.
- W4311108142 date "2022-12-02" @default.
- W4311108142 modified "2023-10-14" @default.
- W4311108142 title "Circulating Galectin-3 in Patients with Cardiogenic Shock Complicating Acute Myocardial Infarction Treated with Mild Hypothermia: A Biomarker Sub-Study of the SHOCK-COOL Trial" @default.
- W4311108142 cites W1974202982 @default.
- W4311108142 cites W1989826879 @default.
- W4311108142 cites W1999134291 @default.
- W4311108142 cites W2001305977 @default.
- W4311108142 cites W2027039566 @default.
- W4311108142 cites W2034154161 @default.
- W4311108142 cites W2034266292 @default.
- W4311108142 cites W2053611837 @default.
- W4311108142 cites W2059677794 @default.
- W4311108142 cites W2067973515 @default.
- W4311108142 cites W2075916197 @default.
- W4311108142 cites W2078016425 @default.
- W4311108142 cites W2094779414 @default.
- W4311108142 cites W2123930114 @default.
- W4311108142 cites W2125373338 @default.
- W4311108142 cites W2130532586 @default.
- W4311108142 cites W2142280282 @default.
- W4311108142 cites W2154227981 @default.
- W4311108142 cites W2155322987 @default.
- W4311108142 cites W2155331090 @default.
- W4311108142 cites W2163026616 @default.
- W4311108142 cites W2169048065 @default.
- W4311108142 cites W2170179774 @default.
- W4311108142 cites W23357194 @default.
- W4311108142 cites W2504743892 @default.
- W4311108142 cites W2553805880 @default.
- W4311108142 cites W2592407084 @default.
- W4311108142 cites W2594892499 @default.
- W4311108142 cites W2608032212 @default.
- W4311108142 cites W2609605008 @default.
- W4311108142 cites W2613346677 @default.
- W4311108142 cites W2734558510 @default.
- W4311108142 cites W2735828659 @default.
- W4311108142 cites W2769708180 @default.
- W4311108142 cites W2775139356 @default.
- W4311108142 cites W2898359979 @default.
- W4311108142 cites W2913342582 @default.
- W4311108142 cites W2915797581 @default.
- W4311108142 cites W2954469331 @default.
- W4311108142 cites W2955729578 @default.
- W4311108142 cites W2967383075 @default.
- W4311108142 cites W2991140140 @default.
- W4311108142 cites W3010158051 @default.
- W4311108142 cites W3026019315 @default.
- W4311108142 cites W3094494803 @default.
- W4311108142 cites W3144873682 @default.
- W4311108142 cites W4205698737 @default.
- W4311108142 cites W4293105230 @default.
- W4311108142 doi "https://doi.org/10.3390/jcm11237168" @default.
- W4311108142 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36498742" @default.
- W4311108142 hasPublicationYear "2022" @default.
- W4311108142 type Work @default.
- W4311108142 citedByCount "4" @default.
- W4311108142 countsByYear W43111081422023 @default.
- W4311108142 crossrefType "journal-article" @default.
- W4311108142 hasAuthorship W4311108142A5021761323 @default.
- W4311108142 hasAuthorship W4311108142A5025672693 @default.
- W4311108142 hasAuthorship W4311108142A5042017136 @default.
- W4311108142 hasAuthorship W4311108142A5042630628 @default.
- W4311108142 hasAuthorship W4311108142A5049481596 @default.
- W4311108142 hasAuthorship W4311108142A5063880800 @default.
- W4311108142 hasAuthorship W4311108142A5065735468 @default.
- W4311108142 hasAuthorship W4311108142A5067592420 @default.
- W4311108142 hasAuthorship W4311108142A5068678356 @default.
- W4311108142 hasAuthorship W4311108142A5087395048 @default.
- W4311108142 hasBestOaLocation W43111081421 @default.
- W4311108142 hasConcept C126322002 @default.
- W4311108142 hasConcept C164705383 @default.
- W4311108142 hasConcept C185592680 @default.
- W4311108142 hasConcept C2776850375 @default.
- W4311108142 hasConcept C2778198053 @default.
- W4311108142 hasConcept C2778488018 @default.
- W4311108142 hasConcept C2780221984 @default.
- W4311108142 hasConcept C2780306776 @default.
- W4311108142 hasConcept C2781197716 @default.
- W4311108142 hasConcept C36880943 @default.
- W4311108142 hasConcept C500558357 @default.
- W4311108142 hasConcept C55493867 @default.
- W4311108142 hasConcept C71924100 @default.
- W4311108142 hasConcept C90924648 @default.
- W4311108142 hasConceptScore W4311108142C126322002 @default.
- W4311108142 hasConceptScore W4311108142C164705383 @default.
- W4311108142 hasConceptScore W4311108142C185592680 @default.